Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events
- 1 November 1995
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 26 (5), 1133-1139
- https://doi.org/10.1016/0735-1097(95)00301-0
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pravastatin, lipids, and major coronary eventsThe American Journal of Cardiology, 1994
- Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart diseaseThe Lancet, 1994
- Platelet aggregation, coronary artery disease progression and future coronary eventsThe American Journal of Cardiology, 1994
- Long-term prognosis of medically treated patients with acute myocardial infarction and one-vessel coronary artery diseaseThe American Journal of Cardiology, 1994
- Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factorsThe American Journal of Cardiology, 1993
- Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I)The American Journal of Cardiology, 1993
- Progression of coronary atherosclerosis: Is coronary spasm related to progression?Journal of the American College of Cardiology, 1991
- Can lifestyle changes reverse coronary heart disease?The Lancet, 1990
- Angiographic progression of coronary artery disease and the development of myocardial infarctionJournal of the American College of Cardiology, 1988
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986